Radial Extracorporeal Shockwave Therapy (rESWT) is not superior to “minimal-dose” rESWT for patients with chronic plantar fasciopathy; a double-blinded randomised controlled trial
Foot and Ankle Surgery(2022)
摘要
Background
Investigating outcomes following radial-extra-corporeal-shockwave-therapy (rESWT) in patients with chronic plantar fasciopathy
Methods
This double-blinded RCT in a single NHS Sports medicine clinic recruited 117 patients with chronic plantar fasciopathy randomised equally to either 3 sessions of rESWT or “minimal-dose” respectively. Mean age 51.7 ± 9.6 years, 66 % female, symptom duration: 32.6 ± 30.8 months.
Results
“Average pain” improved by 50 % at 6-months, (>1/3 at interim time-points). Statistically significant within-group improvements were identified in pain, local function, and “ability” PROMs in both groups. Fewer benefits in activity levels or mood. No between-group differences were seen at the interim or final time-points.
Conclusion
3 sessions of “recommended-dose” rESWT is non-superior to “minimal-dose” rESWT in patients with chronic plantar fasciopathy. rESWT may be ineffective in the treatment of patients with chronic plantar fasciopathy, “minimal-dose” rESWT may be sufficient for a therapeutic effect, or a greater number of treatment sessions may be required for benefit.
Level of evidence
Level I – Randomised controlled trial
更多查看译文
关键词
Plantar fasciopathy,Extracorporeal Shockwave Therapy,Outcome study,Pain
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要